| Fiscal period | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|
| Period End Date | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | 9/30/2015 | 9/30/2014 | 9/30/2013 |
|---|
| Product sales | 54.62 | 46.48 | 44.32 | 40.22 | 37.95 | 32.79 | 31.00 | 24.93 | 22.80 | 22.51 |
| Royalties | -- | -- | -- | -- | 35.42 | -- | -- | -- | -- | -- |
| License fees | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Royalties and license fees | 36.25 | 47.06 | 40.63 | 48.46 | -- | 31.79 | 33.20 | 31.76 | 30.28 | 29.77 |
| Research and development | 9.08 | 11.60 | 9.91 | 11.40 | 7.96 | 8.54 | 7.16 | 5.21 | 4.36 | 3.85 |
| Total Revenues | 99.95 | 105.14 | 94.86 | 100.08 | 81.34 | 73.11 | 71.37 | 61.90 | 57.44 | 56.13 |
| Product | 20.34 | 17.18 | 15.32 | 13.64 | 14.00 | 11.42 | 10.91 | 8.62 | 8.02 | 7.90 |
| Acquired intangible asset amortization | 4.15 | 2.79 | 2.22 | 2.41 | 2.49 | 2.42 | 2.42 | 0.62 | 0.61 | -- |
| Research and development | 50.61 | 46.73 | 50.19 | 52.89 | 40.97 | 31.82 | 18.50 | 16.17 | 15.55 | 15.08 |
| Other research and development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Customer research and development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Acquired in-process research and development | -- | -- | -- | 0.89 | 7.89 | -- | -- | -- | -- | -- |
| Purchased in-process research & development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| General and Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, general and administrative | 46.94 | 30.68 | 28.39 | 23.95 | 24.11 | 20.48 | 18.00 | 14.91 | 14.69 | 13.86 |
| Sales and marketing | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Restructuring charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.48 |
| Acquisition transaction, integration and other costs | -- | 1.05 | -- | -- | -- | -- | 3.19 | -- | -- | -- |
| Asset impairment charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Claim settlement | -- | -- | -- | -- | -- | -- | -- | (2.50) | -- | -- |
| Contingent consideration accretion expense | (0.01) | 0.00 | -- | 0.16 | (0.68) | 0.13 | (1.49) | -- | -- | -- |
| Total Operating Expense | 122.05 | 98.43 | 96.12 | 93.61 | 90.14 | 66.01 | 54.51 | 42.81 | 38.86 | 37.31 |
| Operating income from continuing operations | (22.10) | 6.70 | (1.25) | 6.47 | (8.80) | 7.10 | 16.86 | 19.09 | 18.58 | 18.82 |
| Interest expense | 0.60 | 0.31 | 0.13 | 0.15 | -- | -- | -- | -- | -- | -- |
| Impairment loss on investment | -- | -- | -- | -- | -- | -- | -- | 1.50 | 1.18 | 0.16 |
| Gain on sale of investments and real property | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gains on sale of strategic investments | -- | -- | (0.48) | 0.01 | 0.18 | 0.04 | 0.51 | 0.50 | 0.84 | 1.29 |
| Investment income | 0.10 | 0.12 | 0.66 | 1.10 | 0.85 | 0.39 | 0.06 | 0.16 | 0.24 | 0.27 |
| Other income (loss) | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.14 |
| Foreign exchange loss | 0.10 | (0.17) | (0.25) | 0.13 | 0.24 | (0.50) | (0.48) | -- | -- | -- |
| Other (loss) income, net | (0.40) | (0.36) | (0.20) | 1.09 | -- | (0.07) | 0.09 | (0.85) | -- | 1.54 |
| Income (loss) before income taxes | (22.49) | 6.35 | (1.45) | 7.56 | (7.53) | 7.03 | 16.95 | 18.24 | 18.47 | 20.36 |
| Income tax (benefit) provision | 4.78 | 2.11 | (2.58) | (0.03) | (3.08) | 3.11 | 6.96 | 6.29 | 6.27 | 5.78 |
| Current provision: Federal | (0.51) | 0.26 | (1.57) | 1.36 | -- | -- | -- | 6.07 | -- | -- |
| Current provision: State and foreign | -- | -- | -- | -- | -- | -- | -- | 0.11 | -- | -- |
| Deferred provision (benefit): Federal | 5.20 | 1.85 | (1.34) | -- | -- | -- | -- | 0.06 | -- | -- |
| Deferred provision (benefit): State | 0.52 | (0.06) | 0.20 | -- | -- | -- | -- | 0.04 | -- | -- |
| Current provision: International | -- | -- | -- | -- | -- | -- | -- | 0.03 | -- | -- |
| Income from Continuing Operations | (27.27) | 4.24 | 1.12 | 7.59 | (4.46) | -- | -- | -- | 12.21 | 14.58 |
| Discontinued operations:Income from discontinued operations, net of taxes | -- | -- | -- | -- | -- | -- | -- | -- | (0.18) | 0.59 |
| Discontinued operations:Loss on sale of discontinued operations, net of taxes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Before Extraordinary Income & Accounting Change | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect of a change in accounting principle, net of tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (loss) Available to Common Shareholders | (27.27) | 4.24 | 1.12 | 7.59 | (4.46) | 3.93 | 9.99 | 11.95 | 12.03 | 15.17 |
| Basic net income per share before cumulative effect of a change in accounting principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Continuing operations (Basic) | -- | -- | -- | -- | -- | -- | -- | -- | 0.90 | 1.01 |
| Basic Income (Loss) Per Share:Discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | (0.01) | 0.04 |
| Cumulative effect of a change in accounting principle, net of tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | (1.96) | 0.31 | 0.08 | 0.57 | (0.34) | 0.30 | 0.77 | 0.92 | 0.88 | 1.05 |
| Diluted net income per share before cumulative effect of a change in accounting principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Continuing operations (Diluted) | -- | -- | -- | -- | -- | -- | -- | -- | 0.88 | 0.99 |
| Diluted Income (Loss) Per Share:Discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | (0.01) | 0.04 |
| Cumulative effect of a change in accounting principle, net of tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | (1.96) | 0.30 | 0.08 | 0.55 | (0.34) | 0.29 | 0.76 | 0.90 | 0.87 | 1.03 |
| Weighted Average Shares Outstanding (Basic) | 13.92 | 13.77 | 13.55 | 13.39 | 13.16 | 13.15 | 13.00 | 13.03 | 13.63 | 14.46 |
| Weighted Average Shares Outstanding (Diluted) | 13.92 | 13.99 | 13.81 | 13.78 | 13.16 | 13.39 | 13.22 | 13.29 | 13.88 | 14.73 |